Using of strontium ranelate in the treatment of postmenopausal osteoporosis

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Zazerskaia I.E.

Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova

Kuznetsova L.V.

Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova Minzdravsotsrazvitiia Rossii, Institut perinatologii i pediatrii, NKO reproduktsii i zdorov'ia zhenshchiny, Sankt-Peterburg

Using of strontium ranelate in the treatment of postmenopausal osteoporosis

Authors:

Zazerskaia I.E., Kuznetsova L.V.

More about the authors

Journal: Problems of Endocrinology. 2011;57(2): 46‑51

Read: 1352 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zazerskaia IE, Kuznetsova LV. Using of strontium ranelate in the treatment of postmenopausal osteoporosis. Problems of Endocrinology. 2011;57(2):46‑51. (In Russ.)

Использование инфографики авторами научных работ

Close metadata

Abstract:

The current trends in the diagnostics and treatment of postmenopausal osteoporosis are considered. A review of the results of clinical studies of strontium ranelate in patients with this condition is presented. It is concluded that this agent may be an efficacious tool for the treatment of postmenopausal osteoporosis.

Keywords:

diagnostics

treatment

postmenopausal osteoporosis

strontium ranelate

Authors:

Zazerskaia I.E.

Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova

Kuznetsova L.V.

Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova Minzdravsotsrazvitiia Rossii, Institut perinatologii i pediatrii, NKO reproduktsii i zdorov'ia zhenshchiny, Sankt-Peterburg

Close metadata

References:

et al. Klinicheskie rekomendatsii. Osteoporoz: diagnostika, profilaktika i lechenie. M 2008.
Rozhinskaya L.Ya., Belyaeva A.V., Belaya Zh.E. Ranelat strontsiya (bivalos) - preparat dvoinogo deistviya na kostnuyu tkan'; novye podkhody k lecheniyu osteoporoza. Osteoporoz i osteopatii 2006;1:32-37.
Marie P.J., Ammann P., Boivin G., Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001;69:3:121–129.
Meunier P.J., Roux C., Seeman E. et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:5:459-468.
Meunier P.J., Arlot M.E., Roux J.P. et al. How to rebalance bone turnover in favor of formation. Osteoporosis Int 2006;17:Suppl 1: S114.
Meunier P.J., Slosman D.O., Delmas P.D. et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 2002;87:5:2060-2066.
Malaise O., Bruyere O., Reginster J.Y. Strontium ranelate normalizes bone mineral density in osteopenic patients. Aging Clin Exp Res 2007;19:4:330-333.
Sydney Lou Bonnick. Bone Densitometry in Clinical Practice. Humana Press Inc 2004.
et al. WHO Study Group "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis", Geneva, Switzerland: World Health Organization 1994.
Nielsen P.S., Slosman D., Sorensen O.H. et al. Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry. J Clin Densitomet 1999;2:4:371-379.
Marchenkova L.A., Dreval' A.V., Kryukova I.V. i dr. Effektivnost' bivalosa (strontsiya ranelata) u bol'nykh postmenopauzal'nym osteoporozom, ne prinimayushchikh dobavki kal'tsiya i vitamin D. Probl endokrinol 2010;1:35-41.
Reginster J.Y., Seeman E., De Vernejoul M.C. et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005;90:5:2816-2822.
Rozhinskaya L.Ya., Arapova S.D., Dzeranova L.K. i dr. Rezul'taty rossiiskogo mnogotsentrovogo issledovaniya effektivnosti i perenosimosti bivalosa (strontsiya ranelata) u zhenshchin s postmenopauzal'nym osteoporozom. Osteoporoz i osteopatii 2007;3:24-30.
O'Donnell S., Cranney A., Wells G.A. et al. Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Systematic Review 2006;4:CD005326.
Roux C., Reginster J.Y., Fechtenbaum J. et al. Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 2006;21:4:536-542.
Roux C. (ed) The living skeleton. Wolters Kluwer Health 2007;41-60.
Seeman E., Vellas B., Benhamou C. et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 2006;21:7:1113-1120.
Reginster J.Y., Meuniier P.J., Roux J. et al. Strontium ranelate: an anti-osteoporotic treatment demonstrated vertebral and nonvertebral anti fracture efficacy over 5 years in post menopausal osteoporotic women. Osteoporosis Int 2006;17:Suppl 1:S11-S12.

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.